AZN

Astrazeneca PLC

65.83 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Astrazeneca PLC stock is down -1.89% since 30 days ago. The next earnings date is Apr 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 24 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 50% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Feb 18:32 15 Mar, 2024 62.50 CALL 108 2133
22 Feb 19:28 17 Jan, 2025 60.00 CALL 61 236
22 Feb 20:11 17 Jan, 2025 60.00 CALL 65 236
22 Feb 20:14 17 Jan, 2025 35.00 CALL 10 12
23 Feb 14:39 05 Apr, 2024 64.00 PUT 5670 0
23 Feb 15:28 16 Jan, 2026 62.50 PUT 65 678
23 Feb 15:52 16 Jan, 2026 62.50 PUT 54 678
23 Feb 16:46 16 Jan, 2026 60.00 PUT 75 179
23 Feb 18:19 16 Jan, 2026 50.00 CALL 15 91
23 Feb 20:12 15 Mar, 2024 66.00 CALL 791 984

About Astrazeneca PLC

AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. The company serves primary care and specialty care physicians through distributors in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia.

  • BMO Capital
    Mon Feb 12, 09:57
    buy
    confirm
  • Deutsche Bank
    Thu Feb 8, 11:30
    hold
    downgrade